Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

GOSSAMER BIO, INC. (GOSS)

  • Business News
  • May 11, 2026, 16:51 UTC
  • 0
  • 1 comments

Gossamer Bio, Inc. (GOSS) Faces Securities Class Action Amid 80% Drop On Phase 3 PROSERA Trial Failure- Hagens Berman

Market reaction Comment Full text

BARCLAYS BANK PLC (GBUG)

  • SEC News
  • May 11, 2026, 16:50 UTC
  • 2
  • 0 comments

New Form 424B2 - BARCLAYS BANK PLC <b>Filed:</b> 2026-05-11 <b>AccNo:</b> 0001918704-26-012665 <b>Size:</b> 542 KB

Comment Full text

IMMUNITYBIO, INC. (IBRX)

  • Business News
  • May 11, 2026, 16:50 UTC
  • 0
  • 1 comments

IBRX SHAREHOLDER UPDATE: ImmunityBio (IBRX) Sued After FDA Flags Misleading Cancer Claims, Shares Plunge 21%, $2B Market Cap Lost -- Hagens Berman

Market reaction Comment Full text

CALAMOS GLOBAL TOTAL RETURN FUND (CGO)

  • SEC News
  • May 11, 2026, 16:49 UTC
  • 0
  • 0 comments

New Form DEF 14A - CALAMOS GLOBAL TOTAL RETURN FUND <b>Filed:</b> 2026-05-11 <b>AccNo:</b> 0001104659-26-058601 <b>Size:</b> 1 MB

Comment Full text

CALAMOS CONVERTIBLE & HIGH INCOME FUND (CHY)

  • SEC News
  • May 11, 2026, 16:49 UTC
  • 2
  • 0 comments

New Form DEF 14A - CALAMOS CONVERTIBLE & HIGH INCOME FUND <b>Filed:</b> 2026-05-11 <b>AccNo:</b> 0001104659-26-058601 <b>Size:</b> 1 MB

Comment Full text

CALAMOS STRATEGIC TOTAL RETURN FUND (CSQ)

  • SEC News
  • May 11, 2026, 16:49 UTC
  • 0
  • 0 comments

New Form DEF 14A - CALAMOS STRATEGIC TOTAL RETURN FUND <b>Filed:</b> 2026-05-11 <b>AccNo:</b> 0001104659-26-058601 <b>Size:</b> 1 MB

Comment Full text

CALAMOS CONVERTIBLE OPPORTUNITIES & INCOME FUND (CHI)

  • SEC News
  • May 11, 2026, 16:49 UTC
  • 2
  • 0 comments

New Form DEF 14A - CALAMOS CONVERTIBLE OPPORTUNITIES & INCOME FUND <b>Filed:</b> 2026-05-11 <b>AccNo:</b> 0001104659-26-058601 <b>Size:</b> 1 MB

Comment Full text

CALAMOS CONVERTIBLE AND HIGH INCOME FUND (CPZ)

  • SEC News
  • May 11, 2026, 16:49 UTC
  • 0
  • 0 comments

New Form DEF 14A - Calamos Long/Short Equity & Dynamic Income Trust <b>Filed:</b> 2026-05-11 <b>AccNo:</b> 0001104659-26-058601 <b>Size:</b> 1 MB

Comment Full text

CALAMOS CONVERTIBLE AND HIGH INCOME FUND (CCD)

  • SEC News
  • May 11, 2026, 16:49 UTC
  • 0
  • 0 comments

New Form DEF 14A - Calamos Dynamic Convertible & Income Fund <b>Filed:</b> 2026-05-11 <b>AccNo:</b> 0001104659-26-058601 <b>Size:</b> 1 MB

Comment Full text

CALAMOS CONVERTIBLE AND HIGH INCOME FUND (CHW)

  • SEC News
  • May 11, 2026, 16:49 UTC
  • 0
  • 0 comments

New Form DEF 14A - Calamos Global Dynamic Income Fund <b>Filed:</b> 2026-05-11 <b>AccNo:</b> 0001104659-26-058601 <b>Size:</b> 1 MB

Comment Full text

BARCLAYS BANK PLC (GBUG)

  • SEC News
  • May 11, 2026, 16:49 UTC
  • 0
  • 0 comments

New Form 424B2 - BARCLAYS BANK PLC <b>Filed:</b> 2026-05-11 <b>AccNo:</b> 0001918704-26-012664 <b>Size:</b> 551 KB

Comment Full text

RHINEBECK BANCORP, INC. (RBKB)

  • SEC News
  • May 11, 2026, 16:48 UTC
  • 0
  • 0 comments

New Form S-1/A - Rhinebeck Bancorp, Inc. <b>Filed:</b> 2026-05-11 <b>AccNo:</b> 0001104659-26-058600 <b>Size:</b> 7 MB

Comment Full text

BOYD GAMING CORP (BYD)

  • SEC News
  • May 11, 2026, 16:48 UTC
  • 0
  • 1 comments

Director Thoman A. Randall 🟢 acquired 2.3K shares of BOYD GAMING CORP (BYD) Transaction Date: May 07, 2026 | Filing ID: 000038

Comment Full text

BANK OF MONTREAL /CAN/ (BMO)

  • SEC News
  • May 11, 2026, 16:48 UTC
  • 0
  • 0 comments

New Form FWP - BANK OF MONTREAL /CAN/ <b>Filed:</b> 2026-05-11 <b>AccNo:</b> 0001839882-26-023624 <b>Size:</b> 220 KB

Comment Full text

COTY INC. (COTY)

  • Business News
  • May 11, 2026, 16:48 UTC
  • 0
  • 1 comments

COTY INVESTOR UPDATE: Coty Inc. (COTY) Sued After Surprise Profit Decline, CEO Exit, and Withdrawn 2026 Guidance -- Hagens Berman

Market reaction Comment Full text
  • Previous
  • 407
  • 408
  • 409
  • 410
  • 411
  • Next

Search

News categories

  • Technical Exchange News(12450)
  • Event(6229)
  • SEC News(279335)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(160585)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin